Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective.
Kraft J, van Timmeren JE, Frei S, Mayinger M, Borsky K, Kirchner C, Stark LS, Tanadini-Lang S, Wolpert F, Weller M, Woodruff HC, Guckenberger M, Andratschke N. Kraft J, et al. Among authors: borsky k. Radiother Oncol. 2022 Jul;172:23-31. doi: 10.1016/j.radonc.2022.04.024. Epub 2022 Apr 27. Radiother Oncol. 2022. PMID: 35489445
Distance to isocenter is not associated with an increased risk for local failure in LINAC-based single-isocenter SRS or SRT for multiple brain metastases.
Kraft J, van Timmeren JE, Mayinger M, Frei S, Borsky K, Stark LS, Krayenbuehl J, Zamburlini M, Guckenberger M, Tanadini-Lang S, Andratschke N. Kraft J, et al. Among authors: borsky k. Radiother Oncol. 2021 Jun;159:168-175. doi: 10.1016/j.radonc.2021.03.022. Epub 2021 Mar 30. Radiother Oncol. 2021. PMID: 33798610
Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity.
Fritz C, Borsky K, Stark LS, Tanadini-Lang S, Kroeze SGC, Krayenbühl J, Guckenberger M, Andratschke N. Fritz C, et al. Among authors: borsky k. Front Oncol. 2018 Nov 22;8:551. doi: 10.3389/fonc.2018.00551. eCollection 2018. Front Oncol. 2018. PMID: 30524969 Free PMC article.
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).
Verardi F, Maul LV, Borsky K, Steinmann S, Rosset N, Pons HO, Sorbe C, Yawalkar N, Micheroli R, Egeberg A, Thyssen JP, Heidemeyer K, Boehncke WH, Conrad C, Cozzio A, Pinter A, Kündig T, Navarini AA, Maul JT. Verardi F, et al. Among authors: borsky k. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):719-731. doi: 10.1111/jdv.19730. Epub 2023 Dec 12. J Eur Acad Dermatol Venereol. 2024. PMID: 38084852
External validation of three prognostic scores for brain metastasis velocity in patients treated with intracranial stereotactic radiotherapy.
Christ SM, Borsky K, Kraft J, Frei S, Willmann J, Ahmadsei M, Kirchner C, Stark Schneebeli LS, Camilli F, Tanadini-Lang S, Rahman R, Aizer AA, Guckenberger M, Andratschke N, Mayinger M. Christ SM, et al. Among authors: borsky k. Radiother Oncol. 2023 Dec;189:109917. doi: 10.1016/j.radonc.2023.109917. Epub 2023 Sep 22. Radiother Oncol. 2023. PMID: 37741344 Free article.
24 results